Novartis steps up MS digital presence with iPhone app

Novartis ($NVS) has introduced a multiple sclerosis iPhone app to help patients track their symptoms and relapses, PMLiVE reports. The app allows users to record their symptoms, general well-being, medications and other factors. With patients sometimes going one year between consultations with healthcare professionals, a day-to-day record is likely to be more reliable than memory when recalling symptoms. Article

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The company's Owkin Socrates platform applies transfer and federated learning to clinical research.